| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/01/2012 | EP1333853B1 Growth factor complex |
| 08/01/2012 | EP1328653B1 Highly expressible genes |
| 08/01/2012 | CN102618420A Health-care liquor and manufacturing method thereof |
| 08/01/2012 | CN102617548A Bicycloheteroaryl compounds as GPR Receptor stimulant, compositions and application thereof |
| 08/01/2012 | CN102614165A Use of substituted benzoates (besilates) as selective ligands of estrogen acceptor |
| 08/01/2012 | CN102266359B Method for continuously extracting hypoglycemic active ingredient and estrogen active ingredient from tamariskoid spikemoss herbs |
| 07/31/2012 | US8232068 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 07/31/2012 | CA2539909C 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo(2,3-c) pyridin-2-ylmethyl) pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes |
| 07/26/2012 | WO2012098387A1 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors |
| 07/26/2012 | WO2012098217A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders |
| 07/26/2012 | US20120190748 Greater utility with thyroid hormone |
| 07/26/2012 | US20120190743 Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity |
| 07/26/2012 | US20120189693 Oral dosage forms |
| 07/26/2012 | US20120189686 Transdermal levonorgestrel device and delivery |
| 07/26/2012 | US20120189673 Polypeptides and uses thereof |
| 07/26/2012 | US20120189599 Medication for oral administration, comprising at least one estrogen and/or at least one gestagen and at least one probiotic bacterial strain |
| 07/26/2012 | CA2825124A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders |
| 07/25/2012 | EP2477700A2 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
| 07/25/2012 | EP2018170B1 Medication against breast cancer |
| 07/25/2012 | CN1608078B Gonadotrophins for folliculogenesis |
| 07/25/2012 | CN102612524A Dual variable domain immunoglobulins and uses thereof |
| 07/25/2012 | CN102612376A Growth hormones with prolonged in-vivo efficacy |
| 07/25/2012 | CN102603627A Naphthlamide derivative used as protein kinase inhibitor and histone deacetylase inhibitor and preparation method of naphthlamide derivative |
| 07/25/2012 | CN102600354A Preparation method and standard quality testing method of Yinjusanjie granular preparation |
| 07/25/2012 | CN102600352A Traditional Chinese medicine for treating xerostomia |
| 07/25/2012 | CN102600349A Health-promoting composition and its application |
| 07/25/2012 | CN102600347A Medical composition for softening hardness, dissipating stagnation and removing goitre |
| 07/25/2012 | CN102600189A Application of ginseng secondary saponin and aliphatic ester derivative thereof in preventing and treating diabetes mellitus |
| 07/25/2012 | CN102600176A Application of nilestriol compound in preparing information treatment drug, preparation method and prepared novel drug |
| 07/25/2012 | CN102600144A Roflumilast for the treatment of diabetes mellitus |
| 07/25/2012 | CN102600136A Use of compound thiamazole in preparation of information therapy medicine, preparation method of information therapy medicine, and prepared novel medicine |
| 07/25/2012 | CN101921266B 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof |
| 07/25/2012 | CN101157725B Preparation method of human insulin analogue and usage thereof |
| 07/24/2012 | US8227570 Modified gherlin peptides |
| 07/24/2012 | CA2476065C Inhibitors of histone deacetylase |
| 07/19/2012 | WO2012095461A1 Beverage |
| 07/19/2012 | US20120183610 glucocorticoid therapy |
| 07/19/2012 | US20120183595 Transdermal Pharmaceutical Delivery Composition |
| 07/19/2012 | US20120183563 Iminothiadiazine dioxide compounds as bace inhibitors, compositions and their use |
| 07/18/2012 | EP2476415A2 Treating bone-related disorders with selective androgen receptor modulators |
| 07/18/2012 | EP2475676A2 Pregnane derivatives condensed in the 16,17 position with an N-substituted isoxazolidine ring as anti-inflammatory agents |
| 07/18/2012 | CN1835937B Novel thiazoline derivatives as selective androgen receptor modulators (SARMS) |
| 07/18/2012 | CN1440408B Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 07/18/2012 | CN102596949A 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 07/18/2012 | CN102596194A Combination medicament |
| 07/18/2012 | CN102584937A Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| 07/18/2012 | CN102584741A Amides compound, method for preparing same, composition and application thereof |
| 07/18/2012 | CN102584687A Ethylene derivatives used as selective estrogen receptor modulators |
| 07/18/2012 | CN102580069A Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 07/18/2012 | CN102579808A Medicinal composition for treating hashimoto's disease |
| 07/18/2012 | CN102579673A Application of fresh rehmannia root aqueous extract in preparation of estrogen medicines |
| 07/18/2012 | CN102579671A Drug combination for nourishing yin, supplementing blood and discharging fire |
| 07/18/2012 | CN102579669A Chinese medicinal composition for nourishing qi and blood and conditioning menstruation and preparation method thereof |
| 07/18/2012 | CN102579603A Application of polygonum cuspidatum (PC) in prevention and treatment of insulin resistance and relative metabolic diseases |
| 07/18/2012 | CN102579532A Radix acanthopanacis senticosl composition, preparation containing composition and detection method of preparation |
| 07/18/2012 | CN102579422A Application of flavonoids compound in preparation of anti-metabolic disease medicine |
| 07/18/2012 | CN102578001A Unisexual fry raising technique for walking catfish |
| 07/18/2012 | CN101851238B Substituted 8-heteroaryl xanthines |
| 07/17/2012 | CA2525764C N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| 07/17/2012 | CA2524568C Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof |
| 07/12/2012 | US20120178820 Method for treating arthritis |
| 07/12/2012 | US20120178767 Treatment of liver disorders with p13k inhibitors |
| 07/12/2012 | US20120178741 Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase |
| 07/12/2012 | US20120178697 Compositions and methods for the inhibition of dishevelled proteins |
| 07/12/2012 | US20120178688 Therapeutic agents for reducing parathyroid hormone levels |
| 07/12/2012 | US20120178678 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors |
| 07/12/2012 | US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same |
| 07/12/2012 | US20120177704 Crystalline anti-human il-12 antibodies |
| 07/12/2012 | US20120177699 Preparation Method of Drug Loaded Emulsion |
| 07/12/2012 | US20120177694 Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom |
| 07/11/2012 | EP2473165A1 Combination medicament |
| 07/11/2012 | EP1131052B1 Vaginally administrable progesterone-containing tablets and method for preparing same |
| 07/11/2012 | CN102574903A Acylated glucagon analogues |
| 07/11/2012 | CN102558177A Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 07/11/2012 | CN102558164A Benzopyrone estrogen receptor (ER) modulator |
| 07/11/2012 | CN102558075A Substituted piperazines as CB1 antagonists |
| 07/11/2012 | CN102552996A Personal lubricant |
| 07/11/2012 | CN102552290A Glimepiride medicinal composition tablets and preparation method and application thereof |
| 07/11/2012 | CN102552278A Medicinal composition for enhancing solubility of slightly-soluble medicament tolvaptan |
| 07/11/2012 | CN102552163A Metoprolol tartrate sustained release pellet and preparation method thereof |
| 07/11/2012 | CN102145128B Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof |
| 07/11/2012 | CN101926783B Drug slow control releaser and preparation method thereof |
| 07/11/2012 | CN101701218B Immune regulatory oligodeoxynucleotide for inhibiting differentiation of Th1 and Th17 and application thereof |
| 07/10/2012 | US8217002 Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis |
| 07/10/2012 | CA2477954C Means and methods for the production of adenovirus vectors |
| 07/10/2012 | CA2470207C Matrix film tablet with controlled release of natural mixtures of conjugated estrogens |
| 07/10/2012 | CA2462930C Remodeling and glycoconjugation of peptides |
| 07/10/2012 | CA2446951C Polythiourea lipid derivatives |
| 07/10/2012 | CA2246501C Stabilised growth hormone formulation and method of preparation thereof |
| 07/05/2012 | WO2012092165A1 Transdermal drug delivery system comprising levonorgestrel acetate |
| 07/05/2012 | WO2012089127A1 Certain dipeptidyl peptidase inhibitors |
| 07/05/2012 | WO2012089122A1 Certain dipeptidyl peptidase inhibitors |
| 07/05/2012 | WO2012088677A1 Certain dipeptidyl peptidase inhibitors |
| 07/05/2012 | WO2011085643A8 Fused pyridine derivatives |
| 07/05/2012 | US20120174243 SOGA Polynucleotides and Polypeptides and Uses Thereof |
| 07/05/2012 | US20120172397 HEXAHYDROCYCLOPENTA[f]INDAZOLE 5-YL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 07/05/2012 | US20120172396 2-adamantylurea derivatives as selective 11b-hsd1 inhibitors |
| 07/05/2012 | US20120172393 (4-Phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone Compounds and Their Use |
| 07/05/2012 | US20120172303 Growth Hormones with Prolonged In-Vivo Efficacy |
| 07/05/2012 | US20120172302 Composition for the treatment of benign prostate hyperplasia |